Matches in SemOpenAlex for { <https://semopenalex.org/work/W3046192264> ?p ?o ?g. }
- W3046192264 endingPage "112827" @default.
- W3046192264 startingPage "112827" @default.
- W3046192264 abstract "Piperazine derivatives are an attractive class of chemical compounds for the treatment of various mental illness. Herein, we demonstrated the synthesis of LQFM212, a piperazine derivative, behavioral evaluation in mice and computational studies. In neuropharmacological assessment, LQFM212 treatment at doses of 18, 54 or 162 μmol/kg increased the sleep duration in sodium pentobarbital-induced sleep test. LQFM212 at dose of 162 μmol/kg increased climbing time in the chimney test and decreased the number of squares crossed in the open field test, suggesting that LQFM212 in high doses reduces spontaneous movement. However, LQFM212 treatment at the doses of 18 or 54 μmol/kg increased the preference for the center of field which could be indicative of anxiolytic-like effects. In elevated plus maze and light-dark box tests, LQFM212 treatment altered all parameters observed that demonstrate anxiolytic-like activity. These effects were reversed by flumazenil, mecamylamine, WAY-100635 and PCPA, but not with ketanserin, showing that anxiolytic-like activity involve benzodiazepine site of GABAA receptor, nicotinic and serotonergic pathways. Molecular docking of LQFM212 showed that the ligand has more interactions with GABAA receptor than with 5-HT1A receptor. Despite the involvement of benzodiazepine site on anxiolytic-like effect of LQFM212, treatment with this compound did not alter cognitive function in the step-down avoidance test. In this sense, this piperazine derivative is a good prototype for treating anxiety disorders with putative mechanism of action." @default.
- W3046192264 created "2020-08-03" @default.
- W3046192264 creator A5002496094 @default.
- W3046192264 creator A5003052957 @default.
- W3046192264 creator A5007770033 @default.
- W3046192264 creator A5046679613 @default.
- W3046192264 creator A5054572296 @default.
- W3046192264 creator A5054864065 @default.
- W3046192264 creator A5075209868 @default.
- W3046192264 creator A5078242993 @default.
- W3046192264 creator A5081015885 @default.
- W3046192264 creator A5081482030 @default.
- W3046192264 creator A5086599258 @default.
- W3046192264 date "2020-09-01" @default.
- W3046192264 modified "2023-10-17" @default.
- W3046192264 title "Neuropharmacological assessment in mice and molecular docking of piperazine derivative LQFM212" @default.
- W3046192264 cites W165635918 @default.
- W3046192264 cites W1969972941 @default.
- W3046192264 cites W1972349240 @default.
- W3046192264 cites W1976950210 @default.
- W3046192264 cites W1981305916 @default.
- W3046192264 cites W1982569952 @default.
- W3046192264 cites W1982957594 @default.
- W3046192264 cites W1984277574 @default.
- W3046192264 cites W1989422224 @default.
- W3046192264 cites W1989870541 @default.
- W3046192264 cites W2006332277 @default.
- W3046192264 cites W2009400274 @default.
- W3046192264 cites W2012859687 @default.
- W3046192264 cites W2020255255 @default.
- W3046192264 cites W2024077111 @default.
- W3046192264 cites W2024262269 @default.
- W3046192264 cites W2025816743 @default.
- W3046192264 cites W2026180033 @default.
- W3046192264 cites W2028046413 @default.
- W3046192264 cites W2032058764 @default.
- W3046192264 cites W2034860560 @default.
- W3046192264 cites W2037662525 @default.
- W3046192264 cites W2038477005 @default.
- W3046192264 cites W2041561931 @default.
- W3046192264 cites W2042203193 @default.
- W3046192264 cites W2058355900 @default.
- W3046192264 cites W2064887450 @default.
- W3046192264 cites W2070971788 @default.
- W3046192264 cites W2073924899 @default.
- W3046192264 cites W2080934698 @default.
- W3046192264 cites W2080965426 @default.
- W3046192264 cites W2086847371 @default.
- W3046192264 cites W2095350714 @default.
- W3046192264 cites W2107743363 @default.
- W3046192264 cites W2112877462 @default.
- W3046192264 cites W2114792171 @default.
- W3046192264 cites W2129140710 @default.
- W3046192264 cites W2139405337 @default.
- W3046192264 cites W2149522089 @default.
- W3046192264 cites W2153348560 @default.
- W3046192264 cites W2154550811 @default.
- W3046192264 cites W2156618447 @default.
- W3046192264 cites W2165223719 @default.
- W3046192264 cites W2167549547 @default.
- W3046192264 cites W2179679836 @default.
- W3046192264 cites W2191898358 @default.
- W3046192264 cites W2195092429 @default.
- W3046192264 cites W2218526232 @default.
- W3046192264 cites W2221723423 @default.
- W3046192264 cites W2315034196 @default.
- W3046192264 cites W2327581403 @default.
- W3046192264 cites W2330799739 @default.
- W3046192264 cites W2461169273 @default.
- W3046192264 cites W2471341083 @default.
- W3046192264 cites W2570772893 @default.
- W3046192264 cites W2583010006 @default.
- W3046192264 cites W2585744029 @default.
- W3046192264 cites W2766125113 @default.
- W3046192264 cites W2791091229 @default.
- W3046192264 cites W2801079377 @default.
- W3046192264 cites W2809662941 @default.
- W3046192264 cites W2810911197 @default.
- W3046192264 cites W2884641336 @default.
- W3046192264 cites W2889401614 @default.
- W3046192264 cites W2929069647 @default.
- W3046192264 cites W2990015741 @default.
- W3046192264 cites W4238945726 @default.
- W3046192264 cites W4241526417 @default.
- W3046192264 cites W611557535 @default.
- W3046192264 cites W897824399 @default.
- W3046192264 doi "https://doi.org/10.1016/j.bbr.2020.112827" @default.
- W3046192264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32730857" @default.
- W3046192264 hasPublicationYear "2020" @default.
- W3046192264 type Work @default.
- W3046192264 sameAs 3046192264 @default.
- W3046192264 citedByCount "3" @default.
- W3046192264 countsByYear W30461922642022 @default.
- W3046192264 crossrefType "journal-article" @default.
- W3046192264 hasAuthorship W3046192264A5002496094 @default.
- W3046192264 hasAuthorship W3046192264A5003052957 @default.
- W3046192264 hasAuthorship W3046192264A5007770033 @default.
- W3046192264 hasAuthorship W3046192264A5046679613 @default.